Tenglyn M 20/1000Mgtab (15 Tab)

Each uncoated bilayered Tenglyn M 1000 mg tablet contains Teneligliptin Hydrochloride Hydrate equivalent to Teneligliptin 20 mg, Metformin Hydrochloride 1000 mg (In sustained release form) and Excipients q.s.

Teneligliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones i.e. glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By increasing and prolonging active incretin levels, teneligliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner.

Metformin improves glucose tolerance in patients with type-2 diabetes (NIDDM), lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.

⭐Important Notice⭐

* T & C Apply.
* Product MRP can be changed without prior notice.
* Product offer can be withdrawn, modified, and removed by the company without prior notice.
* Product images sometimes change based on stock availability.
* Delivery lead time can vary depending on traffic and availability.
* product availability as per location-wise stock matters.
* Please check the details of medicines Name, Strength, Quantity, Batch No., Expiry date, etc., with your prescription
Please understand that after accepting the medicines, we shall not be liable or responsible.
* Batch No., MRP, Expiry date, Image, description can be changed as per notice, etc.
* Any suppor,supportt please call/Whatsapp us ‪+91 8101099110‬.

⭐Join WhatsApp Channel For Offer & Updates:-  https://whatsapp.com/channel/0029VagZBQk4yltHfZOmXQ0g

Tenglyn M 20/1000Mgtab (15 Tab) by ZYDUS CADILA

Take control of your type-2 diabetes management with Tenglyn M 20/1000Mgtab, an advanced bilayered tablet designed to improve blood glucose levels effectively and sustainably. Each tablet combines the potent benefits of Teneligliptin and Metformin Hydrochloride, offering superior dual-action support tailored for patients with non-insulin-dependent diabetes mellitus (NIDDM).

Key Features & Benefits:

• Powerful DPP-4 Inhibitor: Teneligliptin works by enhancing incretin hormones like GLP-1 and GIP, promoting insulin release and reducing glucagon levels in a glucose-dependent manner.
• Sustained Glucose Management: Metformin Hydrochloride, in its sustained-release form, improves glucose tolerance by lowering basal and postprandial plasma glucose levels.
• Comprehensive Blood Sugar Regulation: Reduces hepatic glucose production, minimizes intestinal absorption of glucose, and enhances peripheral glucose uptake and utilization for better insulin sensitivity.
• Convenient Dosing: Each tablet is formulated for optimal efficacy, ensuring sustained glucose control